Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares Repurchased
Ratios

SBC Medical Group Holdings (SBC) Loans and Notes Receivables (2023 - 2025)

SBC Medical Group Holdings filings provide 3 years of Loans and Notes Receivables readings, the most recent being $3.1 million for Q3 2025.

  • On a quarterly basis, Loans and Notes Receivables fell 0.93% to $3.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $3.1 million, a 0.93% decrease, with the full-year FY2024 number at $3.1 million, up 2.01% from a year prior.
  • Loans and Notes Receivables hit $3.1 million in Q3 2025 for SBC Medical Group Holdings, roughly flat from $3.1 million in the prior quarter.
  • In the past five years, Loans and Notes Receivables ranged from a high of $3.1 million in Q1 2025 to a low of $3.1 million in Q4 2023.
  • Median Loans and Notes Receivables over the past 3 years was $3.1 million (2024), compared with a mean of $3.1 million.
  • Biggest five-year swings in Loans and Notes Receivables: increased 2.01% in 2024 and later fell 0.93% in 2025.
  • SBC Medical Group Holdings' Loans and Notes Receivables stood at $3.1 million in 2023, then grew by 2.01% to $3.1 million in 2024, then dropped by 1.58% to $3.1 million in 2025.
  • The last three reported values for Loans and Notes Receivables were $3.1 million (Q3 2025), $3.1 million (Q2 2025), and $3.1 million (Q1 2025) per Business Quant data.